Adverum Biotechnologies
Lilly Expands Gene Therapy Presence with Acquisition of Adverum Biotechnologies
Eli Lilly; Adverum Biotechnologies; gene therapy; ophthalmology; wet age-related macular degeneration; ixovec; acquisition; contingent value rights